Related Experiment Video
Updated: Aug 16, 2026

A High-Throughput Multiplexed Screening for Type 1 Diabetes, Celiac Diseases, and COVID-19
Published on: July 5, 2022
[Diagnosis and screening for type 2 diabetes: which test to use?]
1Service de diabétologie, endocrinologie et nutrition, Département de médecine interne, Hôpitaux universitaires de Genève, 1211 Genève 14. michel.procopiou@hcuge.ch
Abstract:
The benefits of screening for type 2 diabetes during its preclinical phase are not well established in comparison to starting a treatment after a diagnosis is made when the patient presents with symptoms of hyperglycaemia. Despite this uncertainty, it seems reasonable that an early treatment could prevent diabetic complications given that the preclinical period can last several years. Opportunistic screening is recommended for high risk individuals (age > or = 45 years, BMI > or = 30, family history of type 2 diabetes, hypertension, dyslipidemia, presence of cardiovascular disease). Among the different screening tests, measurement of fasting plasma glucose is the first choice. The oral glucose tolerance test (OGTT) should not be part anymore of routine practice.
Related Concept Videos
Type II Diabetes Mellitus III: Clinical Manifestations and Diagnosis
Diabetes Mellitus: Type 2 and Gestational
Diabetes: Symptoms, Diagnosis, and Complications
Hyperglycemia
Type II Diabetes I: Introduction
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in the...
